FR2567905B1 - Gene de synthese ou fragment d'adn, cellule hote le comprenant, procede de construction d'un gene de synthese pour une proteine cible virale, et vaccin contenant la proteine - Google Patents

Gene de synthese ou fragment d'adn, cellule hote le comprenant, procede de construction d'un gene de synthese pour une proteine cible virale, et vaccin contenant la proteine

Info

Publication number
FR2567905B1
FR2567905B1 FR8510975A FR8510975A FR2567905B1 FR 2567905 B1 FR2567905 B1 FR 2567905B1 FR 8510975 A FR8510975 A FR 8510975A FR 8510975 A FR8510975 A FR 8510975A FR 2567905 B1 FR2567905 B1 FR 2567905B1
Authority
FR
France
Prior art keywords
synthesis gene
constructing
host cell
dna fragment
same
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
FR8510975A
Other languages
English (en)
Other versions
FR2567905A1 (fr
Inventor
John M Rice
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
GCP Products UK Ltd
WR Grace and Co Conn
Original Assignee
WR Grace Ltd
WR Grace and Co Conn
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by WR Grace Ltd, WR Grace and Co Conn filed Critical WR Grace Ltd
Publication of FR2567905A1 publication Critical patent/FR2567905A1/fr
Application granted granted Critical
Publication of FR2567905B1 publication Critical patent/FR2567905B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/70—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving virus or bacteriophage
    • C12Q1/701—Specific hybridization probes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2760/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssRNA viruses negative-sense
    • C12N2760/00011—Details
    • C12N2760/18011—Paramyxoviridae
    • C12N2760/18611—Respirovirus, e.g. Bovine, human parainfluenza 1,3
    • C12N2760/18622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Analytical Chemistry (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Biotechnology (AREA)
  • Physics & Mathematics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicinal Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
FR8510975A 1984-07-18 1985-07-17 Gene de synthese ou fragment d'adn, cellule hote le comprenant, procede de construction d'un gene de synthese pour une proteine cible virale, et vaccin contenant la proteine Expired FR2567905B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/632,106 US4743553A (en) 1984-07-18 1984-07-18 Synthetic genes for bovine parainfluenza virus

Publications (2)

Publication Number Publication Date
FR2567905A1 FR2567905A1 (fr) 1986-01-24
FR2567905B1 true FR2567905B1 (fr) 1988-03-11

Family

ID=24534103

Family Applications (1)

Application Number Title Priority Date Filing Date
FR8510975A Expired FR2567905B1 (fr) 1984-07-18 1985-07-17 Gene de synthese ou fragment d'adn, cellule hote le comprenant, procede de construction d'un gene de synthese pour une proteine cible virale, et vaccin contenant la proteine

Country Status (10)

Country Link
US (1) US4743553A (fr)
AU (1) AU588238B2 (fr)
BE (1) BE902921A (fr)
DE (1) DE3524736A1 (fr)
DK (1) DK326185A (fr)
ES (1) ES8608581A1 (fr)
FR (1) FR2567905B1 (fr)
GB (1) GB2161814A (fr)
IT (1) IT1187689B (fr)
NL (1) NL8502063A (fr)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987003206A1 (fr) * 1985-11-25 1987-06-04 Quash Gerard A Glycoproteines virales modifiees, utilisations diagnostiques et therapeutiques
AU602875B2 (en) * 1985-12-18 1990-11-01 British Technology Group Limited Newcastle disease virus gene clones
US5149650A (en) * 1986-01-14 1992-09-22 University Of North Carolina At Chapel Hill Vaccines for human respiratory virus
ATE105334T1 (de) * 1988-04-22 1994-05-15 Upjohn Co Schimaerische glykoproteine enthaltende immunogenische abschnitte von menschlichem parainfluenzavirus typ 3.
NZ230425A (en) * 1988-09-02 1992-07-28 Molecular Eng Ass Production of paramyxovirus fusion (f) protein using recombinant baculovirus expression vector
US5401626A (en) * 1989-06-18 1995-03-28 Fujikura Kasei Co., Ltd. cDNA fragment of the gene for the hemagglutinin neuraminidase of human parainfluenza type 2 virus and materials containing the cDNA fragment
JPH0757200B2 (ja) * 1989-06-19 1995-06-21 藤倉化成株式会社 ヒトパラインフルエンザ２型ウイルス同定用検査薬に用いるｄｎａ断片
JP2649285B2 (ja) * 1990-11-29 1997-09-03 藤倉化成株式会社 ヒトパラインフルエンザ４ａ型ウイルスフュージョンプロテイン遺伝子及び該遺伝子を含む物質
JPH10509593A (ja) * 1994-11-18 1998-09-22 バイエル・アクチエンゲゼルシャフト ２の異種系におけるウシ・パラインフルエンザ・ウイルス・タイプ３の血球凝集素／ノイラミニダーゼ（ｈｎ）糖蛋白質の発現
US5869036A (en) * 1995-12-08 1999-02-09 St. Louis University Live attenuated vaccines based on CP45 HPIV-3 strain and method to ensure attenuation in such vaccine
US20040176855A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Decellularized liver for repair of tissue and treatment of organ deficiency
US20040175366A1 (en) * 2003-03-07 2004-09-09 Acell, Inc. Scaffold for cell growth and differentiation

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3501770A (en) * 1967-04-13 1970-03-17 Lilly Co Eli Shipping fever vaccine
DE2323847C3 (de) * 1973-05-11 1979-11-22 Bayer Ag, 5090 Leverkusen Lebendimpfstoff zur Immunisierung von Rindern gegen die Parainfluenza-3-Virus-Infektion
GB1488800A (en) * 1973-11-29 1977-10-12 Wellcome Found Influenza vaccines
US4331589A (en) * 1978-11-22 1982-05-25 Abbott Laboratories Deoxyribonucleic acid synthesis using binding protein extracted from chick embryo fibroblasts
FR2480779B2 (fr) * 1979-08-30 1986-07-18 Anvar Vecteur contenant une sequence nucleotidique de l'antigene de surface du virus de l'hepatite b et procede de fabrication d'une molecule immunogene mettant en oeuvre ce vecteur
US4357421A (en) * 1979-04-02 1982-11-02 G. D. Searle & Co. Synthetic gene coding for influenza hemagglutinin
US4415491A (en) * 1980-01-14 1983-11-15 The Regents Of The University Of California Synthetic vaccine peptide epitomes of hepatitis B surface antigen
US4293545A (en) * 1980-03-31 1981-10-06 Norden Laboratories, Inc. Modified Pasteurella multocida bacteria vaccines
US4388299A (en) * 1980-03-31 1983-06-14 Norden Laboratories, Inc. Modified pasteurella bacteria and vaccines prepared therefrom
US4328210A (en) * 1980-03-31 1982-05-04 Norden Laboratories, Inc. Modified Pasteurella bacteria and vaccines prepared therefrom
US4335106A (en) * 1980-03-31 1982-06-15 Norden Laboratories Inc. Processes for the growth of a modified Pasteurella multocida bacteria and preparation of a vaccine therefrom
US4719177A (en) * 1981-04-20 1988-01-12 Massachusetts Institute Of Technology Production of complementary DNA representing RNA viral sequences by recombinant DNA methods and uses therefor
US4393201A (en) * 1981-11-04 1983-07-12 The Wistar Institute DNA Which codes for glycoprotein of era-strain rabies virus
FR2524487B1 (fr) * 1982-04-05 1985-11-22 Pasteur Institut Fragments d'adn codant pour des polypeptides contenant au moins un determinant antigenique des papillomavirus, notamment du type hpv 1a et polypeptides correspondants
CA1198882A (fr) * 1982-04-08 1986-01-07 Marley Tile A.G. Tuiles pour toitures
WO1983003547A1 (fr) * 1982-04-14 1983-10-27 Bittle, James, L. Antigene synthetique du picornavirus

Also Published As

Publication number Publication date
IT1187689B (it) 1987-12-23
NL8502063A (nl) 1986-02-17
AU4441785A (en) 1986-01-23
IT8521609A0 (it) 1985-07-17
GB8517994D0 (en) 1985-08-21
GB2161814A (en) 1986-01-22
ES545299A0 (es) 1986-07-16
DE3524736A1 (de) 1986-01-30
DK326185A (da) 1986-01-19
DK326185D0 (da) 1985-07-17
ES8608581A1 (es) 1986-07-16
FR2567905A1 (fr) 1986-01-24
AU588238B2 (en) 1989-09-14
BE902921A (fr) 1985-11-18
US4743553A (en) 1988-05-10

Similar Documents

Publication Publication Date Title
FR2567905B1 (fr) Gene de synthese ou fragment d'adn, cellule hote le comprenant, procede de construction d'un gene de synthese pour une proteine cible virale, et vaccin contenant la proteine
Content et al. Secretory proteins induced in human fibroblasts under conditions used for the production of interferon beta.
DK374686A (da) Knoglemorphogenetiske midler, fremgangsmaade til fremstilling deraf og dna-sekvenser, nucleinsyresonder og rekombinante udtrykkelsesmedier til anvendelse derved
DK58985D0 (da) Nukleinsyrereagenser, fremgangsmaade til fremstilling deraf og anvendelse deraf
DE3875667D1 (de) Menschliche papillomavirusnukleinsaeureproben.
BE891659A (fr) Molecules d'adn de recombinant et procedes d'obtention de proteines.
FR2569421B1 (fr) Plasmide et fragment d'adn comprenant un gene pour la resistance a la tetracycline, culture de microorganisme contenant le plasmide precite et microorganisme contenant ledit fragment d'adn
RU93005170A (ru) Нуклеиновые кислоты, применение нуклеиновых кислот, диагностические наборы, вакцины, клетки, белок, применение белка, антитела, применение антител
DK64185A (da) Peptider, farmaceutiske praeparater, gener, vektorer, vaertsorganismer,fremgangsmaader til deres fremstilling og diagnostiske reagenser
FR2670683B1 (fr) Procede et systeme, assiste par ordinateur, pour ameliorer la separation par electrophorese, de macromolecules, notamment de l'adn.
DE69732029D1 (de) Dna enthaltende impfstoffen
FR2579222B1 (fr) Sequence d'adn, vecteur, hote transforme et procede pour preparer un facteur de croissance de l'epiderme, et methode pour depiler un animal au moyen de ce facteur
Vennström et al. Two initiation sites for adenovirus 5.5 S RNA
Lund Heterogeneity of human U snRNAs
FR2604438B1 (fr) Nouveaux conjugues de couplage entre des sequences d'arn ou d'adn et une proteine, leur procede de preparation et leur application biologique
DK94385A (da) Proteiner, farmaceutiske praeparater, gener, vektorer, vaertsorganismer samt fremgangsmaader til deres fremstilling
MC1823A1 (fr) Procede et dispositif pour la detection de genomes viraux a adn et arn dans les milieux biologiques,notamment dans le serum sanguin
DE3673436D1 (de) Gene fuer biologisch aktive proteine.
Nohga et al. Comparison of RNase T1 fingerprints of U1, U2, and U3 small nuclear RNA's of HeLa cells, human normal fibroblasts, and Novikoff hepatoma cells
FR2646606B1 (fr) Retrovirus hautement cytopathogenique hiv-ndk. fragment d'adn de ce retrovirus, procede de preparation d'une proteine et/ou enzyme de ce virus et leurs utilisations
FR2509139B1 (fr) Isolement de proteine microbienne d'une teneur reduite en acides nucleiques
FR2615528B1 (fr) Procede de production d'un polypeptide ayant des proprietes choisies determinees, dans un organisme-hote transforme par un adn recombinant contenant des sequences nucleiques codant pour ce polypeptide et pour une proteine affine d'ose
PT1016714E (pt) Novo adn plasmidico que compreende adn do gene reporter e sua utilizacao
GB8828024D0 (en) Dna having genetic information of l-a-glycerophosphate oxidase & application thereof
FR2699190B1 (fr) Procédé pour favoriser la différenciation de cellules, substances protéiques possédant une activité de transfert de lipides, compositions les contenant, séquences d'ADN et sondes d'oligonucléotides correspondantes.

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse